The open sale of cannabis products in Europe has raised considerations amongst policymakers, each with regard to the authorized standing of those products and their potential for hurt. The products are marketed for his or her low THC (tetrahydrocannabinol) content material, which sellers declare exempt them from management by drug legal guidelines, or as sources of CBD (cannabidiol). This publication presents an preliminary overview of the state of affairs, masking the kinds of low-THC product accessible, consumer profiles, related harms and regulatory responses in Europe. Low-THC products that take kinds much like illicit cannabis products, reminiscent of smoking mixtures, oils and edibles are a main focus of this research. The report highlights the challenges dealing with each policymakers and people wishing to provide low-THC products concerning establishing the authorized standing of the products and which regulatory frameworks apply to their sale.
Series sort: Ad hoc publication
Note: Due to an error, we now have needed to briefly take away the PDF of this publication. It can be made accessible right here once more very shortly. Our apologies for any inconvenice brought about.
Table of contents
- Introduction and rationale
- What are low-THC cannabis products?
- The state of affairs in Europe concerning low-THC products
- Types of low-THC products
- The sale of low-THC products in Europe
- Types of shops
- Origin of the products
- Product high quality
- Marketing of low-THC products
- Product labelling and disclaimers
- Characteristics and motivations of customers of low-THC products
- The regulatory context for low-THC products
- Recent regulatory responses to the rise in low-THC products
- Regulating THC ranges at nationwide degree
- Regulating CBD products
- Quality management and regulation enforcement
- Looking to the long run: what traction do low-THC products have?